Clinical Trial Update: A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how carbamazepine affects the pharmacokinetics of paliperidone extended-release in people with schizophrenia or bipolar disorder; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Carbamazepine (Carbamazepine)
• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Bipolar Disorder | Phase 1 | Status: COMPLETED